Detalhe da pesquisa
1.
Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
Am J Pathol
; 194(5): 828-848, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320632
2.
Association between tumor morphology and efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma.
Hepatol Res
; 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38353524
3.
Novel concept of "sequential particle radiotherapy" with atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus.
Surg Today
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436718
4.
Complete response to tremelimumab plus durvalumab treatment in hepatocellular carcinoma with a bile duct tumor thrombus: A case report.
Oncol Lett
; 28(1): 332, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38807678
5.
IFI16 Induced by Direct Interaction between Esophageal Squamous Cell Carcinomas and Macrophages Promotes Tumor Progression via Secretion of IL-1α.
Cells
; 12(22)2023 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37998338